Clinical Trial Update: Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing trimethoprim-sulfamethoxazole to clindamycin for invasive MRSA infections in children; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenitis
• Mastoiditis
• Methicillin-resistant Staphylococcus Aureus Infection
• Orbital Cellulitis
• Osteomyelitis
• Peritonsillar Abscess
• Retropharyngeal Abscess
• Septic Arthritis

Drugs mentioned

• Clindamycin
• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Indiana University | Conditions: Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute | Phase 4 | Status: RECRUITING